FDA daily

FDA daily for Thursday, May 21, 2026

In this issue: 10 approvals, 2 device recalls and 24 device decisions. 3 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Thu, May 14 FDA approved 5 new applications (1 brand or biologic, 4 generic) and 5 supplements to existing ones.

  • TRETINOIN

    AMNEAL · TRETINOIN

    Prescription topicalsANDA217497Generic (ANDA)Prescription
  • TRIMBOW

    CHIESI · BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE, GLYCOPYRROLATE

    NDA219622Drug (NDA)Discontinued
  • CEFIXIME

    FDC LTD · CEFIXIME

    ANDA218691Generic (ANDA)Prescription
  • GALLIUM GA 68 GOZETOTIDE

    IONETIX · GALLIUM GA-68 GOZETOTIDE

    ANDA219189Generic (ANDA)Prescription
  • L-GLUTAMINE

    PHARMOBEDIENT · L-GLUTAMINE

    ANDA219750Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 2 device recalls from 2 firms on Thu, May 14.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 9 510(k)s and 15 PMA decisions on Thu, May 7, including 1 original PMA.

Browse device clearances and approvals in FDA data →

FDA did not answer for Labels, Drug recalls, Drug shortages, Food and supplement recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.